An experienced litigator of patent infringement and other intellectual property and commercial cases, Don helps clients navigate the rules of a complex regulatory environment in order to reach their business goals.
Don has extensive experience at the trial and appellate level litigating Hatch-Waxman statutory patent infringement and other actions involving prescription pharmaceutical drugs. These include Wellbutrin XL (bupropion), Intuniv (guanfacine), Megace ES (megestrol acetate), Dexilant (dexlansoprazole), Lidoderm (lidocaine), Ambien CR (zolpidem), Intermezzo (zolpidem), Livalo (pitavastatin), Strattera (atomoxetine), Adderall XR (mixed amphetamine salts), Clarinex (desloratadine), Amrix (cyclobenzaprine), Enablex (darifenacin), Cymbalta (duloxetine), Luvox CR (fluvoxamine), Ryzolt (tramadol), Keppra XR (levetiracetam), Mirapex ER (pramipexole), Requip XL (ropinirole), and Wellbutrin SR/Zyban (bupropion). Among Don’s considerable patent litigation forums are injunction hearings, Markman proceedings, trials, and appeals. He has represented clients in patent cases involving a wide range of technologies, including pharmaceuticals, aluminum alloys, silicon on insulator manufacturing, computer software and ergonomic computer accessories.
Don is a member of Husch Blackwell’s Partner Board and Managing Partner of the firm’s Chicago office. Before joining the firm, he was Chief Assistant State’s Attorney in the Cook County State’s Attorney’s Office.